Cadence and NVIDIA Unveil Innovations in Generative AI and Accelerated Computing

Cadence Design Systems, Inc. has announced an expansion of its collaboration with NVIDIA, introducing two groundbreaking solutions that leverage accelerated computing and generative AI. These innovations aim to revolutionize data center design, simulation, drug discovery, and therapeutic design.

Cadence Reality Digital Twin Platform:

The Cadence Reality Digital Twin Platform is a comprehensive solution designed to accelerate the design, simulation, and optimization of data centers across various industries. By leveraging AI, high-performance computing (HPC), and physics-based simulation, the platform significantly improves data center energy efficiency by up to 30%. Integration with NVIDIA Omniverse enhances data center design and simulation workflows, resulting in a 30x acceleration.

Generative AI in Drug Discovery:

Cadence and NVIDIA are collaborating to accelerate drug discovery processes using generative AI. Cadence's cloud-native molecular design platform, Orion, will integrate NVIDIA's generative AI tool, BioNeMo, and microservices for drug discovery. This collaboration aims to enhance therapeutic design capabilities and reduce the time to obtain trusted results. Pharmaceutical companies can leverage on-demand GPU access to generate and assess design hypotheses across various therapeutic modalities.

Insights from Executives:

Dr. Anirudh Devgan, President and CEO of Cadence, emphasizes the transformative impact of the collaboration, particularly in data center design and drug discovery. He highlights the integration of AI technologies to optimize data center operations and drive innovation in therapeutics.